Company profile: MDS Pharma Services
1.1 - Company Overview
Company description
- Provider of drug discovery and development solutions, including global clinical development (project management, clinical monitoring, and regulatory services), data management (integration, customized reports, CDISC-compliant exports), medical and scientific writing (ICH-compliant), independent quality assurance in North America and Europe, and central lab and centralized cardiac safety evaluation services for early drug development.
Products and services
- Data Management: Delivers CDISC-compliant clinical trial data management, integrating trial datasets, generating customized reports, and exporting CDISC-compliant files for studies across phases
- Global Clinical Development: Coordinates global-scale clinical trials by managing and expediting studies through project management, clinical monitoring, and regulatory services
- Medical and Scientific Writing: Produces ICH-compliant clinical study reports, protocols, and regulatory submissions, ensuring compliance with ICH guidelines throughout documentation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MDS Pharma Services
BioSim
HQ: United States
Website
- Description: Provider of solutions to enable and accelerate drug discovery at quantum accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioSim company profile →
3P Biopharmaceuticals
HQ: Spain
Website
- Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
Zenith Technologies
HQ: Ireland
Website
- Description: Provider of global full lifecycle automation, manufacturing, and operational support solutions for the life science industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zenith Technologies company profile →
ShangPharma Innovation
HQ: United States
Website
- Description: Provider of global innovation incubation and investment focused on biomedical R&D technologies and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ShangPharma Innovation company profile →
Noble Pharma
HQ: United States
Website
- Description: Provider of FDA-approved contract development and manufacturing services for extremely palatable animal health products, including formulation and process development; manufacturing of soft chews, creams, ointments, suspensions, tablets, powders, and pastes; clinical supplies; GLP analytical and ICH stability services; regulatory support; packaging with serialization and child-resistant options; and technology transfer and validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noble Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MDS Pharma Services
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MDS Pharma Services
2.2 - Growth funds investing in similar companies to MDS Pharma Services
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MDS Pharma Services
4.2 - Public trading comparable groups for MDS Pharma Services
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →